UNITED BIOMEDICAL INC - 08 Jun 2022 Form 4 Insider Report for Vaxxinity, Inc.

Role: 10%+ Owner
Signature: /s/ Mei Mei Hu, As Director and Officer
Issuer symbol: VAXX on OTC
Transactions as of: 08 Jun 2022
Net transactions value: +$59,386
Form type: 4
Filing time: 10 Jun 2022, 18:14:10 UTC
Previous filing: 28 Apr 2022
Next filing: 21 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VAXX	Class A common stock	Purchase	$29,534	+10,000	+0.02%	$2.95	51,626,366	08 Jun 2022	Direct	F1
transaction	VAXX	Class A common stock	Purchase	$29,852	+10,978	+0.02%	$2.72	51,637,344	09 Jun 2022	Direct	F1
holding	VAXX	Class A common stock						4,212,495	08 Jun 2022	Held by United Biomedical Inc., Asia	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price.
F2	Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.

Content

The price reported is a weighted average price.

Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.